Disease
|
Drug/Important Bio-Agent (IBA)
3 | DNA (Deoxyribonucleic Acid)IBA
01/2021
-
01/2020 |
3 | rheinIBA
01/2021
-
12/2019 |
3 | fosbretabulin (combretastatin A4)IBA
01/2021
-
01/2020 |
3 | Contrast MediaIBA
01/2021
-
12/2019 |
2 | Phosphates (Orthophosphate)IBA
01/2021
-
01/2020 |
2 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2020
-
01/2020 |
1 | Phosphotransferases (Kinase)IBA
09/2023 |
1 | AmidesIBA
09/2023 |
1 | SolventsIBA
09/2023 |
1 | Phosphatidylinositols (Phosphatidylinositol)IBA
11/2021 |
1 | idelalisibIBA
11/2021 |
1 | indoleIBA
11/2021 |
1 | AlkanesIBA
01/2021 |
1 | Therapeutic UsesIBA
01/2020 |
1 | 3,3'-diindolylmethane (diindolylmethane)IBA
01/2020 |
1 | Gallium-68IBA
01/2020 |
1 | GadoliniumIBA
12/2019 |
1 | gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA
12/2019 |
1 | Acetic Acid (Vinegar)FDA LinkGeneric
12/2019 |
1 | NAD (NADH)IBA
06/2019 |
1 | FlavoproteinsIBA
06/2019 |
1 | Biomarkers (Surrogate Marker)IBA
06/2019 |
1 | quinone (benzoquinone)IBA
06/2019 |
|
Therapy/Procedure
|